Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 1/20 | 0.50 |
| ▸ | NPY4R | P50391 | 3/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.47 |
| ▸ | AVPR2 | P30518 | 8/20 | 0.43 |
| ▸ | FPR2 | P25090 | 4/20 | 0.41 |
| ▸ | OXTR | P30559 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19000676 | 0.90 | GBA1 (0.44) | TGM2NPY4RCHRM1MEN1BLM | |
| SCHEMBL19000681 | 0.87 | TGM2 (0.43) | TGM2NPY4RCHRM1AVPR2FPR2 | |
| SCHEMBL19000689 | 0.84 | FOLH1 (0.39) | AVPR2OXTRMEN1USP2POLB | |
| SCHEMBL22963159 | 0.80 | TGM2 (0.53) | TGM2NPY4RCHRM1AVPR2FPR2 | |
| SCHEMBL18087519 | 0.78 | TGM2 (0.62) | TGM2NPY4RCHRM1AVPR2FPR2 | |
| SCHEMBL18067135 | 0.77 | TGM2 (0.60) | TGM2NPY4RCHRM1AVPR2FPR2 | |
| SCHEMBL12119403 | 0.77 | TGM2 (0.61) | TGM2NPY4RCHRM1AVPR2FPR2 | |
| SCHEMBL19000687 | 0.76 | GBA1 (0.44) | MEN1BLMKMT2A | |
| Hydrochloric Acid SCHEMBL13737398 | 0.76 | TGM2 (0.60) | TGM2NPY4RCHRM1AVPR2FPR2 | |
| SCHEMBL27005449 | 0.76 | CA12 (0.39) | AVPR2OXTRMEN1USP2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170175178-A1 | CHROMOGENIC PEROXIDASE SUBSTRATES | DAKO DENMARK APS (DK) | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170175178-A1 | CHROMOGENIC PEROXIDASE SUBSTRATES | MPO, TPO, TYR | TGM2 407/4885NPY4R 1835/4885CHRM1 813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.